Peripheral blood stem cell mobilization for hematopoietic support of radioimmunotherapy in patients with breast carcinoma

Cancer

Volumn 80, Issue 12 SUPPL., 1997, Pages 2728-2732

  Richman, Carol M ^a,b,c   Schuermann, Tina C ^b   Wun, Theodore ^a   Malik, Rajiv ^a   O'Donnell, Robert T ^a   DeNardo, Gerald L ^a   DeNardo, Sally J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Sacramento Medical Foundation Blood Center   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast carcinoma; Peripheral blood stem cells; Radioimmunotherapy; Stem cell mobilization

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; APHERESIS; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MEGADOSE; HEMATOPOIETIC STEM CELL; HUMAN; MONONUCLEAR CELL; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031442529     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19971215)80:12+<2728::aid-cncr52>3.0.co;2-a     Document Type: Conference Paper

References (24)

1. DeNardo SJ, O'Grady LF, Macey DJ, Kroger LA, DeNardo GL, Lamborn KR, et al. Quantitative imaging of mouse L-6 monoclonal antibody in breast cancer patients to develop a therapeutic strategy. Nucl Med Biol 1991;18:621-31.
2. DeNardo SJ, O'Grady LF, Richman CM, DeNardo GL. Overview of radioimmunotherapy in advanced breast cancer using 1-131 chimeric L6. In: Ceriani RL, editor. Antigen and antibody molecular engineering in breast cancer diagnosis and treatment. New York: Plenum Press, 1994:203-11.
3. DeNardo SJ, Mirick GR, Kroger LA, O'Grady LF, Erickson L, Yuan A, et al. The biologic window for ChL6 radioimmunotherapy. Cancer 1994;73:1023-32.
4. 131I-labeled chimeric L6 antibody with peripheral blood progenitor cell transfusion. Cancer Res 1995;55(Suppl):5916s-20s.
5. Richman CM, Weiner RS, Yankee RA. Increase in circulating stem cells following chemotherapy in man. Blood 1976; 47:1031-9.
6. Kessinger A, Armitage IO, Landmark JD, Smith DM, Weisenburger DD. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988;71:723-7.
7. Juttner CA, To LB, Ho JQK, Bardy PG, Dyson PG, Haylock DN, et al. Early lymphohematopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia. Transplant Proc 1988;XX:40-3.
8. Elias A, Ayash L, Anderson K, Wheeler C, Schwartz G, Teppler I, et al. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte - macrophage colony-stimulating factor for hematologic support after high dose intensification for breast cancer. Blood 1992;79:3036-44.
9. Sheridan WP, Begley CG, Juttner CA. Effect of peripheral blood progenitor cells mobilized by Filgrastim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet 1992;339:640-4.
10. To LB, Shepperd KM, Haylock DN, Dyson PG, Charles P, Thorp DL, et al. Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 1990;18:442-4.
11. Howell LP, DeNardo SJ, Levy NB, Lund J, DeNardo GL. Immunohistochemical staining of metastatic ductal carcinomas of the breast by monoclonal antibodies used in imaging and therapy: a comparative study. Int J Biol Markers 1995;10:129-35.
12. Hellström I, Beaumier PL, Hellström KE. Antitumor effects of L-6 and IgG2a antibody that reacts with most human carcinomas. Proc Natl Acad Sci USA 1986;83:7059-63.
13. Adams GP, DeNardo SJ, Amin A, Kroger L, DeNardo GL, Hellström I, et al. Comparison of the pharmacokinetics in mice and the biological activity of murine L-6 and human-mouse chimeric Ch L-6 antibody. Antibody Immunoconj Radiopharm 1992;5:81-95.
14. McEwan AJB, MacLean GD, Hooper HR. Mab 170 H.82: an evaluation of a novel panadenocarcinoma monoclonal antibody labeled with 99-Tc and with 111-In. Nucl Med Commun 1992;13:11-9.
15. Richman C, Wun T, Malik R, Schuermann T. Peripheral blood stem cell mobilization and engraftment using moderate dose cyclophosphamide, etoposide, and G-CSF [abstract]. Blood 1996;88(Suppl):241b.
16. Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 1993;82(9):2605-10.
17. Ghalie R, McLeod B, Richman CM, Kaizer H. Peripheral blood stem cell transplantation: impact on procedure load and workload in an apheresis unit. J Clin Apheresis 1992;7:201-7.
18. Richman CM, Johnson GD. Granulocyte/macrophage progenitor cells from peripheral blood and bone marrow differ in their response to prostaglandin E. Blood 1987; 70:1792-6.
19. Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni MA. Circulation of CD34 hematopoietic stem cells in the peripheral blood of high dose cyclophosphamide treated patients: enhancement by intravenous recombinant granulocyte-macrophage colony stimulating factor. Blood 1989;74:1905-14.
20. Parker LM, Binder N, Allman R, Richman CM, Weiner RS, Yankee RA. Prolonged cryopreservation of human bone marrow. Transplantation 1981;31:454-7.
21. Ohta M, Greenberger JS, Anklesaria P, Bassols A, Massague J. Two forms of transforming growth factor-beta distinguished by multipotential haematopoietic progenitor cells. Nature 1987;329:536-41.
22. Ettinger DS, Finkelstein DM, Abeloff MD, Skeel RT, Stott PB, Frontiera MD, et al. Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study: J Natl Cancer Inst 1992;84:1083-4.
23. Andrews RG, Briddell RA, Knitting GH, Rowley SD, Appelbaum FR, McNiece IK. Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony stimulating factor in non human primates. Blood 1995;85:15-20.
24. Williams SF, Lee WJ, Bender JG, Zimmerman T, Swinney P, Blake M, et al. Selection and expansion of the peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood 1996;87:1687-91.